- Home
- ALB vs JAZZ Comparison
ALB vs JAZZ Comparison
Compare ALB & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALB | JAZZ |
|---|---|---|
| Founded | 1994 | 2003 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 16.1B |
| IPO Year | 1995 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ALB | JAZZ |
|---|---|---|
| Price | $96.89 | $208.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 22 |
| Target Price | $161.78 | ★ $294.64 |
| AVG Volume (30 Days) | ★ 2.3M | 772.2K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.67% | N/A |
| EPS Growth | ★ 48.57 | N/A |
| EPS | 5.87 | ★ 7.17 |
| Revenue | ★ $5,142,733,000.00 | $1,618,693,000.00 |
| Revenue This Year | $18.79 | $10.65 |
| Revenue Next Year | $2.79 | $5.76 |
| P/E Ratio | ★ $16.75 | $29.92 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $88.01 | $128.80 |
| 52 Week High | $221.00 | $266.38 |
Technical Indicators
Market Signals| Indicator | ALB | JAZZ |
|---|---|---|
| Relative Strength Index (RSI) | 27.82 | 27.12 |
| Support Level | N/A | $194.77 |
| Resistance Level | $117.59 | $241.39 |
| Average True Range (ATR) | 2.68 | 7.24 |
| MACD | -0.07 | -1.92 |
| Stochastic Oscillator | 14.94 | 2.01 |
Price Performance
Historical ComparisonAbout ALB Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.